trial · primary record
Icotrokinra
Arthritis, Psoriatic
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 552 |
| Primary completion | 2028-02-04 |
| Primary endpoint | Proportion of Participants who Achieve an American College of Rheumatology (ACR) ACR 20 Response at Week 16 |
| Registry ID | NCT06878404 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:58.302Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06878404
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Icotrokinra · compound